HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.

AuthorsMarianne Canonico, Valérie Olié, Laure Carcaillon, Pascale Tubert-Bitter, Pierre-Yves Scarabin, EStrogen and THromboEmbolism Risk (ESTHER) Study Group
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 99 Issue 1 Pg. 246-8 (Jan 2008) ISSN: 0340-6245 [Print] Germany
PMID18217166 (Publication Type: Letter)
Chemical References
  • ABO Blood-Group System
  • Estrogens, Conjugated (USP)
  • factor V Leiden
  • Estradiol
  • Factor V
Topics
  • ABO Blood-Group System
  • Administration, Cutaneous
  • Administration, Oral
  • Aged
  • Body Mass Index
  • Case-Control Studies
  • Estradiol (administration & dosage, adverse effects)
  • Estrogen Replacement Therapy (adverse effects)
  • Estrogens, Conjugated (USP) (administration & dosage, adverse effects)
  • Factor V (genetics)
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Logistic Models
  • Middle Aged
  • Odds Ratio
  • Postmenopause
  • Risk Assessment
  • Risk Factors
  • Varicose Veins (complications)
  • Venous Thromboembolism (blood, chemically induced, etiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: